Physician profile
Avinash Gupta
NPI 1922084821
$2,050.09
in general payments reported to CMS, 2019-2025
18 companies · $37.91 in 2025
The $37.91 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $624 · 2021: $56.08 · 2022: $123 · 2023: $146 · 2024: $845 · 2025: $37.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $738 · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $737.99 |
| Food and Beverage | $291.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $885.77 | 2019-2024 | |
| Medtronic Vascular, INC. | $636.91 | 2019-2020 | |
| Boston Scientific Corporation | $162.66 | 2022-2023 | |
| Intersect Ent, INC. | $115.31 | 2019 | |
| Angiodynamics, INC. | $32.06 | 2022 | |
| Arbor Pharmaceuticals, INC. | $28.11 | 2021 | |
| Scilex Pharmaceuticals INC. | $25.01 | 2019 | |
| Bard Peripheral Vascular, INC. | $22.60 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.61 | 2025 | Relistor |
| Abbott Laboratories | $21.40 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.30 | 2025 | Jardiance |
| Flowonix Medical Incorporated | $14.98 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.52 | 2021 | |
| Galderma Laboratories, L.P. | $13.45 | 2021 | |
| Pfizer INC. | $13.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $12.84 | 2019 | |
| Stimwave Technologies Incorporated | $10.93 | 2019 | |
| Forte Bio-Pharma LLC | $2.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.